1106 related articles for article (PubMed ID: 19194281)
21. Primary mediastinal liposarcoma: clinicopathologic analysis of 24 cases.
Hahn HP; Fletcher CD
Am J Surg Pathol; 2007 Dec; 31(12):1868-74. PubMed ID: 18043041
[TBL] [Abstract][Full Text] [Related]
22. Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis.
de Vreeze RS; de Jong D; Koops W; Nederlof PM; Ariaens A; Haas RL; van Coevorden F
Int J Cancer; 2011 Feb; 128(4):778-86. PubMed ID: 20473880
[TBL] [Abstract][Full Text] [Related]
23. Primary Retroperitoneal Myxoid Liposarcomas.
Setsu N; Miyake M; Wakai S; Nakatani F; Kobayashi E; Chuman H; Hiraoka N; Kawai A; Yoshida A
Am J Surg Pathol; 2016 Sep; 40(9):1286-90. PubMed ID: 27158758
[TBL] [Abstract][Full Text] [Related]
24. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
25. Liposarcoma in children and young adults: a clinicopathologic and molecular study of 23 cases in one of the largest institutions of China.
Peng R; Li N; Lan T; Chen H; Du T; He X; Chen M; Xie Y; Zhang Z; Zhao W; Zhang H
Virchows Arch; 2021 Sep; 479(3):537-549. PubMed ID: 33738541
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for the recurrence of myxoid liposarcoma: 20 cases with up to 8 years follow-up.
Lemeur M; Mattei JC; Souteyrand P; Chagnaud C; Curvale G; Rochwerger A
Orthop Traumatol Surg Res; 2015 Feb; 101(1):103-7. PubMed ID: 25583234
[TBL] [Abstract][Full Text] [Related]
27. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas.
Hisaoka M; Morimitsu Y; Hashimoto H; Ishida T; Mukai H; Satoh H; Motoi T; Machinami R
Am J Surg Pathol; 1999 Dec; 23(12):1480-92. PubMed ID: 10584701
[TBL] [Abstract][Full Text] [Related]
28. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
Narendra S; Valente A; Tull J; Zhang S
Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
[TBL] [Abstract][Full Text] [Related]
29. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma.
Smith TA; Easley KA; Goldblum JR
Am J Surg Pathol; 1996 Feb; 20(2):171-80. PubMed ID: 8554106
[TBL] [Abstract][Full Text] [Related]
30. Liposarcoma of the oral and salivary gland region: a clinicopathologic study of 18 cases with emphasis on specific sites, morphologic subtypes, and clinical outcome.
Fanburg-Smith JC; Furlong MA; Childers EL
Mod Pathol; 2002 Oct; 15(10):1020-31. PubMed ID: 12379747
[TBL] [Abstract][Full Text] [Related]
31. [Clinical value of fluorescence
Wang W; Li X; Liu P; Dong Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):228-233. PubMed ID: 37042132
[TBL] [Abstract][Full Text] [Related]
32. Paratesticular myxoid/round cell liposarcoma harboring type 3 DDIT3-FUS fusion gene: report of a very rare case.
Zozumi M; Nakai M; Matsuda I; Hao H; Tsukamoto Y; Shiraishi Y; Nojima M; Yamamoto S; Hirota S
Pathol Res Pract; 2013 Feb; 209(2):124-7. PubMed ID: 23276404
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.
Kanoe H; Nakayama T; Hosaka T; Murakami H; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Ron D; Sasaki MS; Toguchida J
Oncogene; 1999 Jan; 18(3):721-9. PubMed ID: 9989822
[TBL] [Abstract][Full Text] [Related]
34. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
Hisaoka M; Tsuji S; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M
Diagn Mol Pathol; 1998 Apr; 7(2):96-101. PubMed ID: 9785008
[TBL] [Abstract][Full Text] [Related]
35. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
[TBL] [Abstract][Full Text] [Related]
36. [From cytogenetics to cytogenomics of adipose tissue tumors: 2. Malignant adipose tissue tumors].
Pedeutour F; Maire G; Sirvent N;
Bull Cancer; 2004 Apr; 91(4):317-23. PubMed ID: 15242313
[TBL] [Abstract][Full Text] [Related]
37. Analysis of CHOP rearrangement in pleomorphic liposarcomas using fluorescence in situ hybridization.
Sugita S; Seki K; Yokozawa K; Tochigi N; Furuta K; Hisaoka M; Hashimoto H; Shimoda T; Hasegawa T
Cancer Sci; 2009 Jan; 100(1):82-7. PubMed ID: 19037998
[TBL] [Abstract][Full Text] [Related]
38. The role of histology, grading, location of tumour and ploidy in evaluation of outcome in patients with liposarcoma.
Harazin-Lechowska A; Ambroziak-Lackowska B; Ryś J; Kruczak A; Gruchała A; Jaszcz-Gruchała A; Dańda D; Przewoźnik M; Halaszka K
Pol J Pathol; 2017; 68(4):343-351. PubMed ID: 29517205
[TBL] [Abstract][Full Text] [Related]
39. [Well-differentiated/dedifferentiated liposarcoma associated with myxoid-like morphology: a clinicopathological and molecular genetic characteristics analysis of 34 cases].
Xue S; Liu QY; Gou XN; Zhao YW; Cheng Q; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):168-173. PubMed ID: 38281785
[No Abstract] [Full Text] [Related]
40. The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.
Göransson M; Andersson MK; Forni C; Ståhlberg A; Andersson C; Olofsson A; Mantovani R; Aman P
Oncogene; 2009 Jan; 28(2):270-8. PubMed ID: 18850010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]